All Title Author
Keywords Abstract


The Current Opinions of Capillary Leak Syndrome

DOI: 10.4236/ojcd.2015.51003, PP. 14-19

Keywords: Capillary Leak Syndrome, Pathogenesis, Treatment, Continuous Blood Purification

Full-Text   Cite this paper   Add to My Lib

Abstract:

Capillary Leak Syndrome (CLS) in patients with severe course of disease is more and more common, and the clinical manifestations of CLS include systemic edema, hypoproteinemia, effective circulating blood volume reduction and hemoconcentration. The common pathogenies are sepsis, severe trauma, cardiopulmonary bypass and so on. Clinically, CLS is usually divided into leakage period and recovery period, with different pathophysiologic process, clinical manifestation and treatment in different period respectively. Although there are more treatments, they are not effective treatment measures. There have been so many studies about improvement of endothelial function, macromolecular colloid liquid applications, and continuous blood purification treatment. Systematic understanding of the pathological mechanism, clinical manifestations and staging, diagnosis and treatment of the CLS has a guiding value.

References

[1]  Lee, Y.S., Kim, S.Y., Kwon, C.W., Song, H.G., Lee, Y.K., Kim, H.J., et al. (2007) Two Cases of Systemic Capillary Leak Syndrome That Were Treated with Pentastarch. The Korean Journal of Internal Medicine, 22, 130-132.
http://dx.doi.org/10.3904/kjim.2007.22.2.130
[2]  Marx, G., Vangerow, B., Burczyk, C., Gratz, K.F., Maassen, N., Cobas Meyer, M., et al. (2000) Evaluation of Noninvasive Determinants for Capillary Leakage Syndrome in Septic Shock Patients. Intensive Care Medicine, 26, 1252-1258.
http://dx.doi.org/10.1007/s001340000601
[3]  Stiller, B., Sonntag, J., Dahnert, I., Alexi-Meskishvili, V., Hetzer, R., Fischer, T., et al. (2001) Capillary Leak Syndrome in Children Who Undergo Cardiopulmonary Bypass Clinical Outcome in Comparison with Complement Activation and C1 Inhibitor. Intensive Care Medicine, 27, 193-200.
http://dx.doi.org/10.1007/s001340000704
[4]  Zhang, Y.L. and Wan, X.R. (2006) Capillary Leak Syndrome. Chinese Journal of Postgraduates of Medicine, 29, 10-13.
[5]  Chihara, R., Nakamoto, H., Arima, H., Moriwaki, K., Kanno, Y., Sugahara, S., et al. (2002) Systemic Capillary Leak Syndrome. Internal Medicine, 41, 953-956.
http://dx.doi.org/10.2169/internalmedicine.41.953
[6]  Feng, X., Ren, B., Xie, W., Huang, Z., Liu, J., Guan, R., et al. (2006) Influence of Hydroxyethyl Starch 130/0.4 in Pulmonary Neutrophil Recruitment and Acute Lung Injury during Polymicrobial Sepsis in Rats. Acta Anaesthesiologica Scandinavica, 50, 1081-1088.
http://dx.doi.org/10.1111/j.1399-6576.2006.01113.x
[7]  St. Yang, G.N., Tang, B.Y., Xiong, W.P., et al. (2007) Hydroxyethyl Starch 130/0.4 in Patients after Cardiopulmonary Bypass Cytokines. Journal of Clinical Healthcare, 10, 367-369.
[8]  Liu, C.J., Liu, L., Xu, F., et al. (2006) Children with Congenital Heart Disease, Capillary Leak Syndrome after Cardiopulmonary Bypass Influencing Factors. Chinese Journal of Practical Pediatrics, 21, 753-755.
[9]  Slutsky, A.S. (1999) Lung Injury Caused by Mechanical Ventilation. Chest, 116, 9S-15S.
http://dx.doi.org/10.1378/chest.116.suppl_1.9S-a
[10]  Zhang, L. and Ning, X.H. (2004) Dose IL-2 Caused 1 Case of Adverse Reactions. Chinese Academy of Medical Sciences, 26, 236.
[11]  Guo, L.Y., Zhao, X.T. and Li, W. (2005) Arsenic Trioxide Treatment of Relapsed Acute Promyelocytic Leukemia Complicated with Capillary Leak Syndrome. Journal of Internal Medicine, 44, 632.
[12]  Oberholzer, A., Oberholzer, C., Moldawer, L.L., Luce, J.M., Yaffe, M.B. and Fink, M.P. (2000) Cytokine Signaling— Regulation of the Immune Response in Normal and Critically Ill States. Critical Care Medicine, 28, N3-N12.
http://dx.doi.org/10.1097/00003246-200004001-00002
[13]  Assier, E., Jullien, V. and Lefort, J. (2005) Constitutive Expression of IL-2Rbeta Chain and Its Effects on IL-2-Induced Vascular Leak Syndrome. Cytokine, 32, 280-286.
http://dx.doi.org/10.1016/j.cyto.2005.10.006
[14]  Railan, D., Fivenson, D.P. and Wittenberg, G. (2000) Capillary Leak Syndrome in a Patient Treated with Interleukin 2 Fusion Toxin for Cutaneous T-Cell Lymphoma. Journal of the American Academy of Dermatology, 43, 323-324.
http://dx.doi.org/10.1067/mjd.2000.106373
[15]  Ma, L.J. and Qin, Y.Z. (2008) Extravascular Lung Water Index and Pulmonary Capillary Permeability Index in the Diagnosis of Pulmonary Edema. Chinese Science Abstracts, 14, 195-196.
[16]  Wang, B. and Guo, J.H. (2004) Cardiac Tamponade. Journal of Cardiac Arrhythmias, 8, 38-39.
[17]  Long, J. (2010) Nephrotic Syndrome 80 Cases. Journal of Clinical Rational Drug Use, 3, 96-97.
[18]  Li, Q., Lu, B.-X. and Wang, Z.J. (2007) Selegiline Treatment of Vasogenic Brain Edema in Experimental Study. Practical Journal of Medicine, 24, 1344-1346.
[19]  Schwartzentruber, D.J. (2001) Guidelines for the Safe Administration of High-Dose Interleukin-2. Journal of Immunotherapy, 24, 287-293.
http://dx.doi.org/10.1097/00002371-200107000-00004
[20]  Zhang, S., Wang, S., Li, Q., Yao, S.L., Zeng, B.H., Ziegelstein, R.C. and Hu, Q.H. (2005) Capillary Leak Syndrome in Children with C4A-Deficiency Undergoing Cardiac Surgery with Cardiopulmonary Bypass: A Double-Blind, Randomized Controlled Study. The Lancet, 366, 556-562.
http://dx.doi.org/10.1016/S0140-6736(05)67099-7
[21]  Marx, G. (2003) Fluid Therapy in Sepsis with Capillary Leakage. European Journal of Anaesthesiology, 20, 429-442.
http://dx.doi.org/10.1097/00003643-200306000-00002
[22]  Tian, Z.M., Jin, T., He, H.Y., et al. (2005) Critically Ill Patients with Capillary Leak Syndrome. Critical Care Medicine, 25, 333-335.
[23]  Tichelli, A. and Gratwohl, A. (2008) Vascular Endothelium as “Novel” Target of Graft-Versus-Host Disease. Best Practice Research Clinical Haematology, 21, 139-148.
http://dx.doi.org/10.1016/j.beha.2008.02.002
[24]  Kalka, C., Masuda, H., Takahashi, T., Gordon, R., Tepper, O., Gravereaux, E., et al. (2000) Vascular Endothelial Growth Factor165 Gene Transfer Augments Circulating Endothelial Progenitor Cells in Human Subjects. Circulation Research, 86, 1198-1202.
http://dx.doi.org/10.1161/01.RES.86.12.1198
[25]  Bahlmann, F.H., De Groot, K., Duckert, T., Niemczyk, E., Bahlmann, E., Boehm, S.M. et al. (2003) Endothelial Progenitor Cell Proliferation and Differentiation Is Regulated by Erythropoietin. Kidney International, 64, 1648-1652.
http://dx.doi.org/10.1046/j.1523-1755.2003.00279.x
[26]  Gilman, A.L., Ozkaynak, M.F., Matthay, K.K., Krailo, M., Yu, A.L., Gan, J., et al. (2009) Phase I Study of ch14.18 with Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children with Neuroblastoma after Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report from the Children’s Oncology Group. Journal of Clinical Oncology, 27, 85-91.
http://dx.doi.org/10.1200/JCO.2006.10.3564
[27]  Kiss, J., Yegutkin, G.G., Koskinen, K., Savunen, T., Jalkanen, S. and Salmi, M. (2007) IFN-β Protects from Vascular Leakage via Up-Regulation of CD73. European Journal of Immunology, 37, 3334-3338.
http://dx.doi.org/10.1002/eji.200737793
[28]  Zheng, X., Liu, B.-Y., Fang, Z.-C., et al. (2011) Effects of Cell Apoptosis on Ventilator-Induced Lung Injury. Journal of Southeast University (Medical Science Edition), 30, 360-363.
[29]  Chrysochoou, G., Marcus, R.J., Sureshkumar, K.K., McGill, R.L. and Carlin, B.W. (2008) Renal Replacement Therapy in the Critical Care Unit. Critical Care Nursing Quarterly, 31, 282-290.
http://dx.doi.org/10.1097/01.CNQ.0000336813.04548.22
[30]  Wang, J.Q., Tao, X.G., Zhang, C.-P., et al. (2007) Continuous Blood Purification in Severe Sepsis Patients with Endothelial Injury. Journal of Emergency Medicine, 16, 514-517.
[31]  Lao, Z.-G., Xiong, X.-L., Wu, H., et al. (2011) Observation on Different Blood Purification Modes for Multiple Organ Dysfunction Syndrome Patients Associated with Acute Renal Failure. Modern Medical Journal, 39, 178-180.

Full-Text

comments powered by Disqus